» Authors » P De Stefano

P De Stefano

Explore the profile of P De Stefano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 705
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Iannotti G, Preti M, Grouiller F, Carboni M, De Stefano P, Pittau F, et al.
Neuroimage Clin . 2021 Jan; 28:102467. PMID: 33395963
Epileptic networks, defined as brain regions involved in epileptic brain activity, have been mapped by functional connectivity in simultaneous electroencephalography and functional magnetic resonance imaging (EEG-fMRI) recordings. This technique allows...
2.
Carboni M, Rubega M, Iannotti G, De Stefano P, Toscano G, Tourbier S, et al.
Clin Neurophysiol . 2019 Nov; 130(12):2193-2202. PMID: 31669753
Objective: Epilepsy is a network disease with epileptic activity and cognitive impairment involving large-scale brain networks. A complex network is involved in the seizure and in the interictal epileptiform discharges...
3.
De Stefano P, Marchignoli M, Pisani F, Cossu G
J Psycholinguist Res . 2019 Aug; 48(6):1363-1375. PMID: 31407217
One primary problem in extremely preterm children is the occurrence of atypical language development. The aim of this study was to explore the components of language (articulatory phonetics, lexicon and...
4.
Borgna-Pignatti C, Cappellini M, De Stefano P, Del Vecchio G, Forni G, Gamberini M, et al.
Ann N Y Acad Sci . 2005 Dec; 1054:40-7. PMID: 16339650
The life expectancy of patients with thalassemia major has significantly increased in recent years, as reported by several groups in different countries. However, complications are still frequent and affect the...
5.
Caocci G, Pisu S, Argiolu F, Giardini C, Locatelli F, Vacca A, et al.
Bone Marrow Transplant . 2005 Nov; 37(2):165-9. PMID: 16299541
Bone marrow transplantation (BMT) represents a potentially curative treatment of thalassemia. For patients without an HLA-identical sibling donor, recourse to an unrelated donor is a practicable option but the candidates...
6.
Pession A, Rondelli R, Basso G, Rizzari C, Testi A, Fagioli F, et al.
Leukemia . 2005 Aug; 19(12):2043-53. PMID: 16107897
Since 1982, four consecutive studies on childhood acute myeloid leukaemia (AML) (namely LAM-82, -87, -87M and -92) have been conducted in Italy by the Associazione Italiana di Ematologia e Oncologia...
7.
Rossi G, Giorgiani G, Comoli P, Nobili B, Salvaneschi L, De Stefano P, et al.
Bone Marrow Transplant . 2003 Apr; 31(6):437-40. PMID: 12665837
Haematopoietic stem cell transplantation (HSCT) represents the treatment of choice for severe bone marrow failure in patients with Fanconi anaemia (FA). When the donor is a compatible relative, the chance...
8.
La Nasa G, Giardini C, Locatelli F, Argiolu F, Vassallo E, Prete A, et al.
Haematologica . 2002 Nov; 87(8 Suppl):58-61. PMID: 12412392
Background And Objectives: Allogeneic bone marrow transplantation (BMT) is a widely accepted therapeutic approach in homozygous beta-thalassemia. However, the majority of patients do not have a genotypically identical donor within...
9.
Zecca M, De Stefano P, Nobili B, Locatelli F
Blood . 2001 Jun; 97(12):3995-7. PMID: 11389047
Immune-mediated, acquired pure red cell aplasia (PRCA) is a rare disorder frequently associated with other autoimmune phenomena. Conventional immunosuppressive treatment is often unsatisfactory. Rituximab is a monoclonal antibody against the...
10.
Bonetti F, Zecca M, Pession A, Messina C, Montagna D, Lanino E, et al.
J Clin Oncol . 1999 Nov; 17(12):3729-35. PMID: 10577844
Purpose: To evaluate the safety and efficacy of a preparative regimen consisting of fractionated total-body radiation (9.9 to 12 Gy) and melphalan (140 mg/m(2) in a single dose) in children...